Somerset facility State-of-the art facility for clinical and commercial manufacturing of oral dosage forms. Ghent, Belgium, ...

CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.

Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...

Catalent entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in ...

Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to ...

New Jersey to private contract drug manufacturer Ardena, the companies said on Monday. A data-deletion firm that has filed over 140 lawsuits against businesses accused of running afoul of a New ...

Ghent, Belgium, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the ...

Catalent (NYSE:CTLT) is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to ...

Catalent, Inc. (CTLT), a provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer ...

Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent GlobeNewswire October 14, 2024 Ghent, Belgium, Oct. 14, 2024 (GLOBE ...